(E)-N'-(4-cyanobenzylidene)isonicotinohydrazide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: (E)-N'-(4-cyanobenzylidene)isonicotinohydrazide
• 英文别名: 4-cyanobenzaldehyde isonicotinoylhydrazone；N'-(4-cyanobenzylidene)isonicotinohydrazide；N-[(E)-(4-cyanophenyl)methylideneamino]pyridine-4-carboxamide
• 化学式: C₁₄H₁₀N₄O
• 分子量: 250.26
• InChiKey: KPJHKIZXTUPRIR-LICLKQGHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  78.1
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  异烟肼 、 4-氰基苯甲醛 以 乙醇 、 水 为溶剂， 生成 (E)-N'-(4-cyanobenzylidene)isonicotinohydrazide
  参考文献：
  名称：

  Synthesis and anti-mycobacterial activity of (E)-N′-(monosubstituted-benzylidene)isonicotinohydrazide derivatives

  摘要：

  A series of 22 (E)-N'-(monosubstituted-benzylidene)isonicotinohydrazide derivatives have been synthesized and evaluated for their in vitro antibacterial activity against Mycobacterium tuberculosis H37RV using Alamar Blue susceptibility test and the activity expressed as the minimum inhibitory concentration (MIC) in mu g/mL. Compounds 2f, 2g, 2j, 2k and 2q exhibited a significant activity (0.31-0.62 mu g/mL) when compared with first line drugs such as isoniazid (INH) and rifampicin (RIP) and could be a good starting point to develop new lead compounds in the fight against multi-drug resistant tuberculosis. (c) 2007 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2007.08.003

文献信息

• Synthesis and anti-mycobacterial activity of (E)-N′-(monosubstituted-benzylidene)isonicotinohydrazide derivatives
  作者：Maria Cristina da Silva Lourenço、Marcelle de Lima Ferreira、Marcus Vinícius Nora de Souza、Mônica Amado Peralta、Thatyana Rocha Alves Vasconcelos、Maria das Graças M.O. Henriques

  DOI：10.1016/j.ejmech.2007.08.003

  日期：2008.6

  A series of 22 (E)-N'-(monosubstituted-benzylidene)isonicotinohydrazide derivatives have been synthesized and evaluated for their in vitro antibacterial activity against Mycobacterium tuberculosis H37RV using Alamar Blue susceptibility test and the activity expressed as the minimum inhibitory concentration (MIC) in mu g/mL. Compounds 2f, 2g, 2j, 2k and 2q exhibited a significant activity (0.31-0.62 mu g/mL) when compared with first line drugs such as isoniazid (INH) and rifampicin (RIP) and could be a good starting point to develop new lead compounds in the fight against multi-drug resistant tuberculosis. (c) 2007 Elsevier Masson SAS. All rights reserved.
• 4-Cyanobenzaldehyde isonicotinoylhydrazone monohydrate: a three-dimensional hydrogen-bonded framework structure
  作者：Marcus V. N. de Souza、Solange M. S. V. Wardell、James L. Wardell、John N. Low、Christopher Glidewell

  DOI：10.1107/s0108270107002788

  日期：2007.3.15

  In the title compound, (C14H10N4OH2O)-H-., the molecular components are linked into a three-dimensional framework by three hydrogen bonds, one each of the O - (HO)-O-..., O - H N-... and N - (HO)-O-... types, weakly augmented by two C - (HO)-O-... hydrogen bonds.
• Structure-based optimization of oxadiazole-based GSK-3 inhibitors
  作者：Fabio Lo Monte、Thomas Kramer、Jiamin Gu、Martin Brodrecht、Johannes Pilakowski、Ana Fuertes、Juan Manuel Dominguez、Batya Plotkin、Hagit Eldar-Finkelman、Boris Schmidt

  DOI：10.1016/j.ejmech.2012.06.006

  日期：2013.3

  Inhibition of glycogen synthase kinase-3 (GSK-3) induces neuroprotective effects, e.g. decreases beta-amyloid production and reduces tau hyperphosphorylation, which are both associated with Alzheimer's disease (AD). The two isoforms of GSK-3 in mammalians are GSK-3 alpha and beta, which share 98% homology in their catalytic domains. We investigated GSK-3 inhibitors based on 2 different scaffolds in order to elucidate the demands of the ATP-binding pocket [1]. Particularly, the oxadiazole scaffold provided potent and selective GSK-3 inhibitors. For example, the most potent inhibitor of the present series, the acetamide 26d, is characterized by an IC50 of 2 nM for GSK-3 alpha and 17 nM for GSK-3 beta. In addition, the benzodioxane 8g showed up to 27-fold selectivity for GSK-3 alpha over GSK-3 beta, with an IC50 of 35 nM for GSK-3 alpha. Two GSK-3 inhibitors were further profiled for efficacy and toxicity in the wild-type (wt) zebrafish embryo assay to evaluate simultaneously permeability and safety. (C) 2012 Elsevier Masson SAS. All rights reserved.